M&A Deal Summary

ADQ Acquires Birgi Mefar Group

On June 13, 2022, ADQ acquired life science company Birgi Mefar Group from Stage Capital

Acquisition Highlights
  • This is ADQ’s 2nd transaction in the Life Science sector.
  • This is ADQ’s 1st transaction in Turkey.

M&A Deal Summary

Date 2022-06-13
Target Birgi Mefar Group
Sector Life Science
Buyer(s) ADQ
Sellers(s) Stage Capital
Deal Type Add-on Acquisition

Target

Birgi Mefar Group

Istanbul, Turkey
Birgi Mefar Group is a Turkish pharmaceuticals contract manufacturing and services group, servicing many of the world’s leading pharmaceutical companies through a fully integrated business model. Birgi Mefar Group was founded in 1963 and is based in Istanbul. Turkey.

Search 205,615 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ADQ

Abu Dhabi, United Arab Emirates

Category Company
Founded 2018
Sector Business Services
DESCRIPTION

ADQ is a holding company with direct and indirect investments with portfolio of key sectors across Abu Dhabi's economy, including food and agriculture, aviation, financial services, healthcare, industries, logistics, media, real estate, tourism and hospitality, transport and utilities. ADQ was founded in 2018 and is based in Abu Dhabi, UAE.


DEAL STATS #
Overall 4 of 4
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 3 of 3
Country (Turkey) 1 of 1
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-16 Acino

Zurich, Czech Republic

Acino is a pharmaceutical company focused on developing, manufacturing and marketing well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino was founded in 1836 and is based in Zurich, Czech Republic.

Buy -

Seller(S) 1

SELLER

Stage Capital

London, United Kingdom

Investor Investor Investor Investor


Category Private Equity Firm
Founded 2000
PE ASSETS 900M EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Stage Capital is a private equity firm that seeks investments in middle-market businesses operating in traditional industries serving as the 'backbone' of the economy. The Firm focuses its investment activity across the UK and Europe and looks for opportunities valued between €10 and €15 million where Stage Capital can invest €5 to €25 million. Stage Capital will not invest in start-ups or early stage companies. Stage Capital was formed in 2000 and is based in London with additional offices in Paris and Istanbul.


DEAL STATS #
Overall 20 of 20
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 7 of 7
Country (Turkey) 1 of 1
Year (2022) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-28 Praticima

Villefranche-sur-Saone, France

Praticima designs and manufactures medical equipment, elaborated in partnership with healthcare professionals and designed by an integrated engineering department. Praticima is based in Villefranche-sur-Saone, France.

Sell -